Eli Lilly and Company
Utility Patents

Last updated:

List of all Eli Lilly and Company patents 128 in total

Status Patent
Grant
Utility: CD226 agonist antibodies External link
Filling date: 18 Sep 2025 Issue date: 13 Sep 2022
Grant
Utility: Dose detection module for a medication delivery device External link
Filling date: 18 Sep 2025 Issue date: 13 Sep 2022
Grant
Utility: Dose detection for a medication delivery device External link
Filling date: 18 Sep 2025 Issue date: 30 Aug 2022
Grant
Utility: (trifluoromethyl)pyrimidine-2-amine compounds External link
Filling date: 18 Sep 2025 Issue date: 16 Aug 2022
Grant
Utility: Methods of using interleukin-10 for treating diseases and disorders External link
Filling date: 18 Sep 2025 Issue date: 16 Aug 2022
Grant
Utility: [1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetes External link
Filling date: 18 Sep 2025 Issue date: 2 Aug 2022
Grant
Utility: BTLA agonist antibodies and uses thereof External link
Filling date: 18 Sep 2025 Issue date: 26 Jul 2022
Grant
Utility: Pharmaceutical compositions External link
Filling date: 18 Sep 2025 Issue date: 5 Jul 2022
Grant
Utility: Targeted treatment of mature T-cell lymphoma External link
Filling date: 18 Sep 2025 Issue date: 5 Jul 2022
Grant
Utility: Lysophosphatidic acid receptor 1 (LPAR1) inhibitor compounds External link
Filling date: 18 Sep 2025 Issue date: 21 Jun 2022
Grant
Utility: GIP/GLP1 agonist compositions External link
Filling date: 18 Sep 2025 Issue date: 14 Jun 2022
Grant
Utility: Zero position sensing system for medication delivery device External link
Filling date: 18 Sep 2025 Issue date: 14 Jun 2022
Grant
Utility: System for accelerated testing of silicone drainage in syringes External link
Filling date: 18 Sep 2025 Issue date: 7 Jun 2022
Grant
Utility: Anti-PD-L1-anti-TIM-3 bispecific antibodies External link
Filling date: 18 Sep 2025 Issue date: 7 Jun 2022
Grant
Utility: Automatic injection device and a button thereof External link
Filling date: 18 Sep 2025 Issue date: 7 Jun 2022
Grant
Utility: Anti-Tim-3 antibodies for combination with anti-PD-1 antibodies External link
Filling date: 18 Sep 2025 Issue date: 7 Jun 2022
Grant
Utility: Rotary plunger pump subsystems External link
Filling date: 18 Sep 2025 Issue date: 31 May 2022
Grant
Utility: CD200R agonist antibodies and uses thereof External link
Filling date: 18 Sep 2025 Issue date: 3 May 2022
Grant
Utility: Anti-N3pGlu amyloid beta peptide antibodies and uses thereof External link
Filling date: 18 Sep 2025 Issue date: 26 Apr 2022
Grant
Utility: Automatic injection system External link
Filling date: 18 Sep 2025 Issue date: 12 Apr 2022
Grant
Utility: Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer External link
Filling date: 18 Sep 2025 Issue date: 12 Apr 2022
Grant
Utility: Pyrrolidine compounds External link
Filling date: 18 Sep 2025 Issue date: 29 Mar 2022
Grant
Utility: Determination of a dose in a medication delivery device using two moving arrays with teeth and a sensor External link
Filling date: 18 Sep 2025 Issue date: 8 Mar 2022
Grant
Utility: Methods of detecting human IL-21 External link
Filling date: 18 Sep 2025 Issue date: 8 Mar 2022
Grant
Utility: GIPR-agonist compounds External link
Filling date: 18 Sep 2025 Issue date: 22 Feb 2022
Grant
Utility: Fusion proteins and methods of use External link
Filling date: 18 Sep 2025 Issue date: 22 Feb 2022
Grant
Utility: Neuregulin-4 compounds and methods of use External link
Filling date: 18 Sep 2025 Issue date: 8 Feb 2022
Grant
Utility: Anti-ANGPTL 3/8 complex antibodies and methods of using the same External link
Filling date: 18 Sep 2025 Issue date: 8 Feb 2022
Grant
Utility: Medication delivery device with mechanical locking system External link
Filling date: 18 Sep 2025 Issue date: 25 Jan 2022
Grant
Utility: 2,3-dihydrofuro[2,3-b]pyridine compounds External link
Filling date: 18 Sep 2025 Issue date: 4 Jan 2022
Grant
Utility: Cyclohexyl benzamide compounds External link
Filling date: 18 Sep 2025 Issue date: 4 Jan 2022
Grant
Utility: KCNQ potentiators External link
Filling date: 18 Sep 2025 Issue date: 28 Dec 2021
Grant
Utility: Rapid-acting insulin compositions External link
Filling date: 18 Sep 2025 Issue date: 28 Dec 2021
Grant
Utility: Checkpoint inhibitor bispecific antibodies External link
Filling date: 18 Sep 2025 Issue date: 21 Dec 2021
Grant
Utility: Treatment of primary biliary cholangitis and primary sclerosing cholangitis with baricitinib External link
Filling date: 18 Sep 2025 Issue date: 14 Dec 2021
Grant
Utility: Medication delivery device with gear set dosage system External link
Filling date: 18 Sep 2025 Issue date: 23 Nov 2021
Grant
Utility: [1,2,4]Triazolo[4,3-A]pyrazin-6(5H)-one derivatives External link
Filling date: 18 Sep 2025 Issue date: 23 Nov 2021
Grant
Utility: MET antibody drug conjugates External link
Filling date: 18 Sep 2025 Issue date: 9 Nov 2021
Grant
Utility: Inhibiting the transient receptor potential al ion channel External link
Filling date: 18 Sep 2025 Issue date: 2 Nov 2021
Grant
Utility: Protein tyrosine-tyrosine analogs and methods of using the same External link
Filling date: 18 Sep 2025 Issue date: 26 Oct 2021
Grant
Utility: Disubstituted pyrazole compounds External link
Filling date: 18 Sep 2025 Issue date: 21 Sep 2021
Grant
Utility: Status sensing systems within an injection device assembly External link
Filling date: 18 Sep 2025 Issue date: 21 Sep 2021
Grant
Utility: Imidazolidine compounds External link
Filling date: 18 Sep 2025 Issue date: 21 Sep 2021
Grant
Utility: Rapid-acting insulin compositions External link
Filling date: 18 Sep 2025 Issue date: 21 Sep 2021
Grant
Utility: CHK1/2 inhibitors and irinotecan for use in the treatment of rhabdomyosarcoma External link
Filling date: 18 Sep 2025 Issue date: 21 Sep 2021
Grant
Utility: Selective estrogen receptor degraders External link
Filling date: 18 Sep 2025 Issue date: 14 Sep 2021
Grant
Utility: Isoquinolin and naphthydrin compounds External link
Filling date: 18 Sep 2025 Issue date: 14 Sep 2021
Grant
Utility: Growth differentiation factor 15 agonist compounds and methods of using the same External link
Filling date: 18 Sep 2025 Issue date: 31 Aug 2021
Grant
Utility: GIP/GLP1 co-agonist compounds External link
Filling date: 18 Sep 2025 Issue date: 10 Aug 2021
Grant
Utility: Anti-N3pGlu amyloid beta peptide antibodies and uses thereof External link
Filling date: 18 Sep 2025 Issue date: 3 Aug 2021

Showing 1 to 50 of 128 patents.